BlackRock, Inc. 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | BlackRock Inc. BLK | 9,610,239 8.500% | 7,662,206 (+393.33%) | Filing |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | CymaBay Therapeutics, Inc. CBAY | BlackRock Inc. BLK | 1,948,033 2.300% | -3,376,095 (-63.41%) | Filing |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | BlackRock Inc. BLK | 5,324,128 6.300% | -62,116 (-1.15%) | Filing |
| 2021-01-29 09:57 am Sale | 2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | BlackRock Inc. BLK | 5,386,244 7.800% | -203,607 (-3.64%) | Filing |
| 2020-02-05 11:45 am Purchase | 2019-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | BlackRock Inc. BLK | 5,589,851 8.100% | 428,270 (+8.30%) | Filing |